Paydirt
KW
Insider

Kerry Wentworth

CHIEF REGULATORY OFFICER

Kerry Wentworth (CHIEF REGULATORY OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Nuvation Bio Inc. (NUVB). The largest single filing was $904K of NUVB (200,000 sh × $4.52, as filed), executed Apr 6.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Jun 23
Filed Jun 24

Median ADV $43.2M across their filed names

Open performance
Volume by month
$1.1M$544K$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · sells $1.1MJun 2026 · sells $379K
Buys $0 Sells $1.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
NUVB Nuvation Bio Inc. NUVB · 0 buys · 3 sells 3 filings
Recent filings
NUVBSALE Nuvation Bio Inc. View filing → $379K
63,000 sh × $6.02
Exec Jun 23
Filed Jun 24 · 5:30 PM ET
NUVBSALE Nuvation Bio Inc. View filing → $184K
36,750 sh × $5.01
Exec Apr 17
Filed Apr 21 · 5:30 PM ET
NUVBSALE Nuvation Bio Inc. View filing → $904K
200,000 sh × $4.52
Exec Apr 6
Filed Apr 8 · 5:30 PM ET